A Phase 2 Study to Assess the Safety of EI-1071 and the Effects of EI-1071 on Neuroinflammation in Alzheimer's Disease Patients
Elixiron Immunotherapeutics (Hong Kong) Ltd.
Elixiron Immunotherapeutics (Hong Kong) Ltd.
The University of Hong Kong
Korea University
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
University of Texas at Austin
Stanford University
University of Washington
Appalachian State University
Helse Stavanger HF
Baylor University